PUBLISHER: The Business Research Company | PRODUCT CODE: 2127593
PUBLISHER: The Business Research Company | PRODUCT CODE: 2127593
A ribonucleic acid (RNA) isolation kit is a laboratory reagent system designed to extract and purify RNA from biological samples for molecular analysis. It facilitates the separation of RNA from proteins, DNA, lipids, and other cellular components while preserving RNA quality and integrity. These kits enable efficient RNA extraction for downstream research, diagnostic, and analytical applications.
The primary product types of ribonucleic acid (RNA) isolation kits include standard kits, specialized kits, and high-throughput kits. Standard kits refer to extraction products designed to isolate and purify RNA from biological samples for downstream molecular analysis. These kits are designed for source types including animal tissue and plant tissue. The key applications include molecular biology, genomics, transcriptomics, clinical diagnostics, and pharmaceutical research, while the end-users include academic research institutions, contract research organizations, pharmaceutical companies, and biotechnology companies.
Tariffs are influencing the ribonucleic acid (RNA) isolation kit market by increasing the cost of imported reagents, consumables, and precision laboratory instruments required for RNA extraction workflows. This is disrupting procurement timelines for research laboratories, diagnostic centers, and pharmaceutical companies, particularly in import-dependent regions such as Asia-Pacific and Latin America. High-throughput and automated extraction kit segments are experiencing the greatest impact due to their dependence on globally sourced enzymes, plastics, and magnetic components. However, tariffs are driving regional manufacturing expansion, supplier diversification, and increased investment in domestic life sciences production ecosystems, improving long-term supply chain resilience and cost optimization.
The ribonucleic acid (rna) isolation kit market research report is one of a series of new reports from The Business Research Company that provides ribonucleic acid (rna) isolation kit market statistics, including ribonucleic acid (rna) isolation kit industry global market size, regional shares, competitors with a ribonucleic acid (rna) isolation kit market share, detailed ribonucleic acid (rna) isolation kit market segments, market trends and opportunities, and any further data you may need to thrive in the ribonucleic acid (rna) isolation kit industry. This ribonucleic acid (rna) isolation kit market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The ribonucleic acid (RNA) isolation kit market size has grown strongly in recent years. It will grow from $1.76 billion in 2025 to $1.93 billion in 2026 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be attributed to growth in molecular biology research funding, expansion of genomics and transcriptomics studies, rising prevalence of infectious diseases requiring molecular diagnostics, increasing adoption of laboratory automation systems in research labs, development of column based and spin based extraction technologies.
The ribonucleic acid (RNA) isolation kit market size is expected to see strong growth in the next few years. It will grow to $2.72 billion in 2030 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to integration of AI driven laboratory workflow optimization, increasing demand for precision medicine and personalized therapeutics, expansion of decentralized and point of care diagnostics, rising adoption of automated high throughput extraction platforms, growth in cell free and exosomal ribonucleic acid research applications. Major trends in the forecast period include automated magnetic bead based ribonucleic acid isolation for high efficiency sample processing, rise in ultra low input and single cell ribonucleic acid extraction workflows, growing adoption of RNase free and contamination resistant purification chemistries, expansion of viral ribonucleic acid isolation kits for infectious disease diagnostics, increasing demand for portable and rapid point of care ribonucleic acid extraction solutions.
The growing prevalence of infectious diseases is expected to propel the growth of the ribonucleic acid (RNA) isolation kit market going forward. Infectious diseases are illnesses caused by pathogenic microorganisms, including bacteria, viruses, fungi, or parasites, that spread through direct contact, contaminated surfaces, or environmental exposure. The prevalence of infectious diseases is increasing due to rapid urbanization, as densely populated urban settings promote greater person-to-person interaction and accelerate the transmission of communicable pathogens. Ribonucleic acid (RNA) isolation kits support infectious disease management by enabling the extraction and purification of high-quality RNA required for accurate molecular diagnostics and pathogen detection. For instance, in March 2024, according to the Centers for Disease Control and Prevention, a US-based national public health agency, tuberculosis cases in the United States increased from 8,320 cases in 2022 to 9,615 cases in 2023, reflecting an increase of 1,295 cases. Therefore, the growing prevalence of infectious diseases is driving the growth of the ribonucleic acid (RNA) isolation kit market.
Major companies operating in the ribonucleic acid (RNA) isolation kit market are focusing on developing automated RNA extraction integration solutions, such as viral nucleic acid extraction kits, to improve nucleic acid purification efficiency, enhance diagnostic accuracy, reduce manual processing time, and support high-throughput molecular testing workflows. Viral nucleic acid extraction kits are laboratory solutions designed to isolate and purify viral DNA or RNA from biological samples for molecular analysis and diagnostic applications. For instance, in October 2025, Xpedite Diagnostics GmbH, a Germany-based provider of viral nucleic acid extraction kits and rapid nucleic acid extraction technologies, launched SwiftX Virus to improve rapid viral nucleic acid extraction efficiency, enhance molecular diagnostic accuracy, and support high-throughput testing for tropical and vector-borne diseases. The SwiftX Virus kit features a CE-IVD-certified one-step extraction workflow designed for the rapid isolation of both viral DNA and RNA from clinical samples.
In January 2024, MACHEREY-NAGEL, a Germany-based provider of scientific analysis solutions and manufacturer of ribonucleic acid (RNA) isolation kits, partnered with SARSTEDT to launch the NucleoSpin Dx RNA Blood kit, a CE-IVD-certified RNA isolation kit developed for the purification of RNA from human blood samples. Through this collaboration, MACHEREY-NAGEL aimed to strengthen its molecular diagnostics portfolio by integrating its expertise in nucleic acid isolation with SARSTEDT's blood collection and RNA stabilization technologies, enabling reliable and standardized RNA-based diagnostic testing. SARSTEDT is a Germany-based provider of clinical blood collection and laboratory solutions.
Major companies operating in the ribonucleic acid (RNA) isolation kit market report are Roche Diagnostics International AG, Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., Cytiva, Bio-Rad Laboratories Inc., QIAGEN N.V., Promega Corporation, Takara Bio Inc., MP Biomedicals LLC, Analytik Jena GmbH+Co. KG, MACHEREY-NAGEL GmbH & Co. KG, New England Biolabs Inc., Zymo Research Corporation, Bioneer Corporation, Shanghai Yeasen Biotechnology Co. Ltd., TIANGEN Biotech (Beijing) Co. Ltd., Geneaid Biotech Ltd., HiMedia Laboratories Pvt. Ltd., Norgen Biotek Corp., Vazyme Biotech Co. Ltd., Illumina Inc., Revvity Inc., Covaris LLC, LGC Biosearch Technologies
North America was the dominating region in the ribonucleic acid (RNA) isolation kit market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the ribonucleic acid (RNA) isolation kit market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the ribonucleic acid (RNA) isolation kit market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The ribonucleic acid (RNA) isolation kit market consists of sales of ribonucleic acid (RNA) extraction kits, ribonucleic acid (RNA) purification reagents, spin columns, magnetic bead-based ribonucleic acid (RNA) isolation systems, and ribonucleic acid (RNA) stabilization solutions. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Ribonucleic Acid (RNA) Isolation Kit Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses ribonucleic acid (rna) isolation kit market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for ribonucleic acid (rna) isolation kit ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ribonucleic acid (rna) isolation kit market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.